Target price | $37.43 |
Course | $7.38 |
Price potential |
407.16%
register free of charge
|
Number of estimates | 7 |
7 Analysts have issued a price target Outlook Therapeutics, Inc. 2025 .
The average Outlook Therapeutics, Inc. target price is $37.43.
This is
407.16%
register free of charge
$53.00
618.16%
register free of charge
$25.00
238.75%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend Outlook Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst estimates: Analysts believe that the Outlook Therapeutics, Inc. share has an average upside potential 2025 of
407.16%
register free of charge
|
Sep '23 |
2024 Forecast |
|
---|---|---|
Earnings per share $ | -4.72 | -6.46 |
1,422.58% | 36.86% | |
P/E ratio | negative |
2 Analysts have issued a Outlook Therapeutics, Inc. forecast for earnings per share. The average Outlook Therapeutics, Inc. <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Outlook Therapeutics, Inc....
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.